Atlas Trials

Schizotypal Personality Disorder Risperidone

Clinical trial NCT02535156 · COMPLETED

Trial details

NCT number
NCT02535156
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Schizotypal Personality Disorder
Start date
2003-01-01
Primary completion
2014-01-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.